Novo Nordisk A/S, BlackRock, and Blackstone are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to achieve above-average revenue and earnings growth compared to the overall market. These firms typically reinvest profits into expanding operations rather than paying dividends, which often leads to higher price-to-earnings ratios. Investors buy growth stocks for their potential capital appreciation, though they can carry greater volatility and risk. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NYSE:NVO traded up $2.05 during trading on Friday, hitting $74.70. 9,535,540 shares of the company were exchanged, compared to its average volume of 6,905,079. The stock has a market capitalization of $335.22 billion, a P/E ratio of 22.71, a PEG ratio of 0.90 and a beta of 0.66. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.74 and a quick ratio of 0.55. Novo Nordisk A/S has a 12-month low of $57.00 and a 12-month high of $148.15. The firm's 50 day moving average price is $65.87 and its 200-day moving average price is $80.54.
Read Our Latest Research Report on NVO
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
Shares of NYSE:BLK traded up $4.80 during trading on Friday, hitting $990.26. 623,159 shares of the company were exchanged, compared to its average volume of 690,393. The stock has a market capitalization of $153.42 billion, a P/E ratio of 23.58, a PEG ratio of 1.90 and a beta of 1.41. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.23 and a quick ratio of 5.23. BlackRock has a 12-month low of $752.30 and a 12-month high of $1,084.22. The firm's 50 day moving average price is $925.28 and its 200-day moving average price is $973.18.
Read Our Latest Research Report on BLK
Blackstone (BX)
Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.
Shares of NYSE:BX traded up $2.66 during trading on Friday, hitting $140.42. 3,676,336 shares of the company were exchanged, compared to its average volume of 3,794,968. The stock has a market capitalization of $102.46 billion, a P/E ratio of 38.68, a PEG ratio of 1.07 and a beta of 1.65. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.71. Blackstone has a 12-month low of $115.66 and a 12-month high of $200.96. The firm's 50 day moving average price is $135.47 and its 200-day moving average price is $157.46.
Read Our Latest Research Report on BX
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novo Nordisk A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.
While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.